Bellerophon Therapeutics Inc (BLPH)
0.056
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Bellerophon Therapeutics Total Assets (Quarterly): 4.979M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 4.979M |
June 30, 2023 | 11.24M |
March 31, 2023 | 15.97M |
December 31, 2022 | 7.935M |
September 30, 2022 | 12.61M |
June 30, 2022 | 17.73M |
March 31, 2022 | 21.74M |
December 31, 2021 | 26.88M |
September 30, 2021 | 31.32M |
June 30, 2021 | 37.08M |
March 31, 2021 | 42.19M |
December 31, 2020 | 50.24M |
September 30, 2020 | 57.04M |
June 30, 2020 | 62.65M |
March 31, 2020 | 11.58M |
December 31, 2019 | 13.11M |
September 30, 2019 | 16.61M |
June 30, 2019 | 20.58M |
March 31, 2019 | 24.79M |
Date | Value |
---|---|
December 31, 2018 | 18.36M |
September 30, 2018 | 23.64M |
June 30, 2018 | 29.82M |
March 31, 2018 | 35.89M |
December 31, 2017 | 36.81M |
September 30, 2017 | 40.87M |
June 30, 2017 | 22.36M |
March 31, 2017 | 25.76M |
December 31, 2016 | 29.70M |
September 30, 2016 | 22.78M |
June 30, 2016 | 26.28M |
March 31, 2016 | 31.22M |
December 31, 2015 | 38.41M |
September 30, 2015 | 49.16M |
June 30, 2015 | 62.37M |
March 31, 2015 | 75.18M |
December 31, 2014 | 33.39M |
September 30, 2014 | 48.63M |
December 31, 2013 | 3.636M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.979M
Minimum
Sep 2023
62.65M
Maximum
Jun 2020
25.64M
Average
19.15M
Median
Total Assets (Quarterly) Benchmarks
Janux Therapeutics Inc | 380.41M |
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.256M |
Shareholders Equity (Quarterly) | 3.723M |